Clinical Trials Arena on MSN

Kamada enrols first subject in Cytogam trial for CMV infection

The controlled multi-centre, randomised, prospective trial is investigating the therapy in kidney transplant recipients.
Business Insider

Kamada Announces First Patient Enrolled into an Investigator-Initiated Clinical Trial of CYTOGAM® to Prevent Cytomegalovirus in Kidney Transplantation

REHOVOT, Israel, and HOBOKEN, N.J. , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ...
Hosted on MSN

Moderna scraps mRNA vaccine in congenital CMV on Phase III failure

Moderna is terminating the development of an mRNA vaccine in congenital cytomegalovirus (CMV) after it failed to show any significant benefit in a Phase III trial. Top line data from the CMVictory ...
News Medical

First primate model can help researchers to study mother-to-fetus CMV infections

Cytomegalovirus (CMV) is the leading infectious cause of birth defects worldwide, but scientists have been frustrated in their efforts to develop a vaccine to protect against infections. Among the ...